Citrus Aurantium and anxiety in the last month of pregnancy

Investigating the effect of Citrus Aurantium blossom on anxiety in the last month of pregnancy and reducing postpartum depression

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210926052594N1

Enrollment

100

Registered

2021-10-09

Start date

2021-10-12

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety. Anxiety disorder due to known physiological condition

Interventions

Intervention 1: Intervention group: 500mg Citrus aurantium capsules taken orally BID for 6 weeks (from the 36th week of pregnancy to 2 weeks postpartum). Intervention 2: Control group: placebo capsule

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Having informed consent Being literate Being over 36 weeks pregnant Low-risk pregnancy

Exclusion criteria

Exclusion criteria: History of allergy to herbal medicines History of chronic disease Addiction or drug abuse

Design outcomes

Primary

Measure	Time frame
Beck anxiety score. Timepoint: Baseline, immediately after delivery, 2 weeks postpartum. Method of measurement: Beck Anxiety Inventory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Ahmadinia

Shahre-kord University of Medical Sciences

Fateme.ahmadiniaa@gmail.com+98 938 793 2492

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 24, 2026